Cite
HARVARD Citation
Jackson, W. et al. (2019). A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy. Radiotherapy and oncology. pp. 101-107. [Online].